Open AccessA contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets
Author(s) -
Mohammad Asim,
Brijesh Sathian,
Indrajit Banerjee,
Jared Robinson
Publication year - 2020
Language(s) - English
Resource type - Journals
ISSN - 2091-0800
DOI - 10.3126/nje.v10i4.33964
Subject(s) - pandemic , covid-19 , intensive care medicine , medicine , disease , coronavirus , population , metabolomics , bioinformatics , virology , infectious disease (medical specialty) , biology , pathology , outbreak , environmental health
The Coronavirus disease 2019 (COVID-19) pandemic is caused by rapidly spreading pathogenic virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that affects vast majority of population worldwide. Although, around 80% of the cases had mild infection but still remaining 20% had developed respiratory failure and dysfunction of other organs that necessitate urgent oxygen therapy or specific interventions. Therefore, it is imperative to establish novel prognostic approaches to screen patients at high-risk of developing severe complications. The primary focus of current research for COVID-19 is to discover safe and efficacious vaccine for prevention and effective treatment for better management of the patients to overcome the pandemic. To achieve this goal, it is imperative to have better understanding of the molecular pathways involved in the pathophysiology and progression of severe COVID-19. The surge for reliable diagnostics and therapeutics targets for COVID-19 highlighted the great potential of high-throughput approach like metabolomics which may enable the development of personalized medicine.